Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacotherapy of Treatment-Resistant Mania
NCT00518947Phase 3Completed
- Sponsor
- University of Pittsburgh
- Start
- Nov 1994
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of verapamil in mania (3 arms), sponsored by University of Pittsburgh. Primary endpoints: Bech-Rafaelsen Mania Scale at 3 weeks and Clinical Global Impressions scale at 3 weeks. Started Nov 1994; status: completed.
02
Drugs
verapamil
03
Conditions
mania
Beyond the preview
Go deeper on NCT00518947.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00518947.